Abstract
The early reports of COVID-19 came from Wuhan, China in early December, 2019 with clusters of cases of severe pneumonia (1). Since then, reports of new onset diabetes (NODM) and diabetic ketoacidosis have been published (2, 3). This study aims to estimate the incidence of NODM among patients with COVID-19 admitted to a hospital in Basra, southern Iraq.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
